Stent Position Is More Important than alpha-Blockers or Anticholinergics for Stent-Related Lower Urinary Tract Symptoms after Ureteroscopic Ureterolithotomy: A Prospective Randomized Study.
10.4111/kju.2010.51.9.636
- Author:
Sun Ju LEE
1
;
Changhee YOO
;
Cheol Young OH
;
Yong Seong LEE
;
Sung Tae CHO
;
Seong Ho LEE
;
Dae Yul YANG
;
Sang Kon LEE
;
Jin Seon CHO
Author Information
1. Department of Urology, College of Medicine, Hallym University, Chuncheon, Korea. js315@hallym.or.kr
- Publication Type:Original Article ; Randomized Controlled Trial
- Keywords:
Adrenergic alpha-antagonists;
Cholinergic antagonists;
Ureteroscopy;
Urinary catheterization;
Urological manifestations
- MeSH:
Adrenergic alpha-Antagonists;
Analgesics;
Benzhydryl Compounds;
Cholinergic Antagonists;
Cresols;
Humans;
Lower Urinary Tract Symptoms;
Phenylpropanolamine;
Prospective Studies;
Prostate;
Stents;
Sulfonamides;
Ureter;
Ureteroscopy;
Urinary Catheterization;
Urological Manifestations;
Tolterodine Tartrate
- From:Korean Journal of Urology
2010;51(9):636-641
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To evaluate the clinical factors that impact ureteral stent-related lower urinary tract symptoms (LUTS) after ureteroscopic ureterolithotomy, including the stent position and medication. MATERIALS AND METHODS: Fifty-three patients who underwent ureteroscopic ureterolithotomy with indwelling a stent were distributed into three groups. On demand analgesics were given to the group 1 (n=18). Daily tamsulosin 0.2 mg was added for group 2 (n=15) and daily tamsulosin 0.2 mg and tolterodine 4 mg was added for group 3 (n=20). The patients were also subclassified into appropriate or inappropriate group according to stent position. All the patients completed a visual analogue scale (VAS) and International Prostate Symptom Score (IPSS) on the 1st and 7th postoperative days. The VAS and IPSS were analyzed according to the medication groups and the stent position. RESULTS: In the appropriate stent potion group, only the storage symptom scores of groups 2 and 3 on the 1st postoperative day were significantly lower than those of the group 1 (p=0.001). This medication effect on LUTS was not observed in the inappropriate stent position group. In this group, total IPSS (p=0.015) and storage symptom scores (p=0.002) were higher than in the appropriate stent position group on the 7th postoperative day. CONCLUSIONS: Correct placement of the stent was more important than medication for lessening stent-related storage symptoms.
